The latest quarterly R&D expense is $30.90 Million with a QoQ Growth of +3.03%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2027 (2026-07-31).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2027 (2026-07-31): $30.90M.
$30.90M
$30.90 Million
Q2 FY2027 · 2026-07-31
+3.03%
vs. $29.99M prior quarter
35
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2027Period end 2026-07-31 | $30.90M | +3.03% | 0.00% |
| Q1 FY2027Period end 2026-04-30 | $29.99M | -7.94% | -11.92% |
| Q4 FY2026Period end 2026-01-31 | $32.57M | +10.73% | -5.89% |
| Q3 FY2026Period end 2025-10-31 | $29.42M | -4.79% | -14.15% |
| Q2 FY2026Period end 2025-07-31 | $30.90M | -9.25% | -11.94% |
| Q1 FY2026Period end 2025-04-30 | $34.05M | -1.63% | -8.62% |
| Q4 FY2025Period end 2025-01-31 | $34.61M | +1.00% | -1.72% |
| Q3 FY2025Period end 2024-10-31 | $34.27M | -2.34% | -0.01% |
| Q2 FY2025Period end 2024-07-31 | $35.09M | -5.83% | -3.71% |
| Q1 FY2025Period end 2024-04-30 | $37.26M | +5.81% | +11.20% |
| Q4 FY2024Period end 2024-01-31 | $35.22M | +2.75% | +1.87% |
| Q3 FY2024Period end 2023-10-31 | $34.27M | -5.95% | -2.09% |
| Q2 FY2024Period end 2023-07-31 | $36.44M | +8.75% | +7.14% |
| Q1 FY2024Period end 2023-04-30 | $33.51M | -3.07% | +7.09% |
| Q4 FY2023Period end 2023-01-31 | $34.57M | -1.24% | +25.12% |
| Q3 FY2023Period end 2022-10-31 | $35.00M | +2.91% | +42.56% |
| Q2 FY2023Period end 2022-07-31 | $34.01M | +8.71% | +48.47% |
| Q1 FY2023Period end 2022-04-30 | $31.29M | +13.25% | +51.90% |
| Q4 FY2022Period end 2022-01-31 | $27.63M | +12.52% | +54.68% |
| Q3 FY2022Period end 2021-10-31 | $24.55M | +7.18% | +51.98% |
| Q2 FY2022Period end 2021-07-31 | $22.91M | +11.21% | +47.47% |
| Q1 FY2022Period end 2021-04-30 | $20.60M | +15.33% | +37.20% |
| Q4 FY2021Period end 2021-01-31 | $17.86M | +10.55% | +28.95% |
| Q3 FY2021Period end 2020-10-31 | $16.16M | +4.00% | +28.03% |
| Q2 FY2021Period end 2020-07-31 | $15.54M | +3.47% | +33.52% |
| Q1 FY2021Period end 2020-04-30 | $15.01M | +8.40% | +37.67% |
| Q4 FY2020Period end 2020-01-31 | $13.85M | +9.76% | +58.17% |
| Q3 FY2020Period end 2019-10-31 | $12.62M | +8.46% | -13.44% |
| Q2 FY2020Period end 2019-07-31 | $11.63M | +6.68% | +49.09% |
| Q1 FY2020Period end 2019-04-30 | $10.91M | +24.54% | +41.29% |
| Q4 FY2019Period end 2019-01-31 | $8.76M | -39.93% | +31.55% |
| Q3 FY2019Period end 2018-10-31 | $14.58M | +86.80% | N/A |
| Q2 FY2019Period end 2018-07-31 | $7.80M | +1.10% | N/A |
| Q1 FY2019Period end 2018-04-30 | $7.72M | +15.95% | N/A |
| Q4 FY2018Period end 2018-01-31 | $6.66M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
